香港，2025年7月31日 - (亞太商訊 via SeaPRwire.com) - 近日，國泰海通集團下屬公司國泰君安國際控股有限公司（「國泰君安國際」或「公司」，股份代號：1788.HK）成功發行首筆數碼原生債券。本次發行是首筆由中資券商發行的公募數碼原生債券，採用直發結構，以美元計價，規模不超過3億美元，期限3年，國泰君安國際同時作爲牽頭全球協調人以及結算交割行，並以滙豐的HSBC Orion1作爲數碼資産平台。數碼債券是一種利用區塊鏈或分布式賬本技術發行的債券，其核心特點是數字化、可編程、可自動執行，具有更高透明度，並能降低結算風險和成本。近年來，國泰君安國際在金融創新領域不斷突破，積極引領數字金融及數字資産業務的創新發展，本次數碼債券的發行是其布局區塊鏈技術與數字化金融的重要舉措之一。2025年上半年，公司向香港證監會提交數碼債券發行業務計劃，獲香港證監會確認對該計劃無進一步問題，正式啓動數碼債券發行業務。國泰君安國際財務總監張學明先生表示：「作爲首家成功發行公募數碼原生債券的中資券商，我們履行了對金融創新的堅定承諾，證明了公司在數字金融領域的專業能力，爲推動數字資産的發展貢獻了力量。同時，此次交易不僅提升了客戶與投資者的運營效率和透明度，而且鞏固了國泰君安國際在開拓新一代資本市場解决方案中的領導地位。」滙豐數碼資産及貨幣集團主管 John O’Neill先生表示：「我們十分高興，能協助國泰君安國際完成香港首筆由中資券商發行的數碼債券。此次交易充分展現了HSBC Orion的能力，以配合更多數碼債券及發行人所需。隨著愈來愈多企業和金融機構瞭解數碼債券的優勢，滙豐將繼續致力提高數碼固定收益産品的流動性。」公司將以此次發行爲契機，不斷探索跨境數字資産流通、綠色金融數字化等創新方向，致力於爲全球金融市場提供更多數字化解决方案，助力國際金融體系的智能化轉型與可持續發展。注：1.HSBC Orion 是滙豐建立的分布式分類帳技術（DLT）平台，連接于中央債券結算系統（CMU），作爲DLT平台的運營商，以發行和結算數字原生票據等。關於國泰君安國際國泰海通集團下屬公司國泰君安國際（股票代號：1788.HK）, 是中國證券公司國際化的先行者和引領者，公司是首家通過IPO于香港聯合交易所主板上市的中資證券公司。國泰君安國際以香港爲業務基地，幷在新加坡、越南和澳門設立子公司，業務覆蓋全球主要市場，爲客戶境外資産配置提供高品質、多元化的綜合性金融服務，核心業務包括經紀、企業融資、資産管理、貸款及融資與金融産品等，業務覆蓋個人金融（財富管理）、機構金融（機構投資者服務與企業融資服務）與投資管理三大維度。目前，國泰君安國際已分別獲得穆迪和標準普爾授予「Baa2」及「BBB+」長期發行人評級，MSCI ESG「A」評級, Wind ESG「A」評級及商道融綠ESG「A」評級，同時其標普全球ESG評分領先全球84%同業。公司控股股東國泰海通證券（股票代號：601211.SH/ 2611.HK）爲中國資本市場長期、持續、全面領先的綜合金融服務商。更多關于國泰君安國際的資訊請見:https://www.gtjai.com Copyright 2025 亞太商訊 via SeaPRwire.com.
Shoucheng Buys Back 20M Shares in 2 Days, Signals Strong Bet
HONG KONG, July 31, 2025 - (ACN Newswire via SeaPRwire.com) - Shoucheng Holdings Limited (0697.HK) has reaffirmed its confidence in long-term fundamentals by executing aggressive share buybacks on July 29 and 30, acquiring a total of 20.65 million shares at a cost of HK$37.93 million, with prices ranging from HK$1.80 to HK$1.87 per share.This is part of a broader buyback strategy—since early July, the company has repurchased over 36 million shares, totaling more than HK$66 million in capital deployed. According to management, these buybacks reflect not only near-term valuation confidence, but also long-term belief in the company’s strategic directions in robotics and healthcare technology."The buyback is not just about stabilizing the share price. It is an expression of long-term commitment to our shareholders and a vote of confidence in the commercial potential of our robotics and healthcare portfolios," the management stated.Portfolio Companies Advance Toward IPO MilestonesShoucheng’s capital return strategy is complemented by strong progress across its portfolio. Two of its most high-profile investees—IMUNOPHARM and Unitree Robotics—are now officially preparing for IPOs, signaling a near-term value realization window.IMUNOPHARM, a pioneer in China's CAR-T therapy space, signed a listing guidance agreement with CITIC Securities on July 23, 2025, officially launching its STAR Market IPO process. Meanwhile, Unitree Robotics signed its IPO guidance agreement earlier in July. Founded in 2016, Unitree is globally recognized for its leadership in quadruped and humanoid robotics, having pioneered the mass commercialization of high-performance legged robots. Its humanoid robots, the H1 and G1, are already in the market and featured at major global events including CES and the CCTV Spring Festival Gala. Unitree has filed over 200 patent applications and maintained profitability since 2020, with annual revenue exceeding RMB 1 billion.The dual IPO progression of IMUNOPHARM and Unitree not only validates Shoucheng’s early-stage investment judgment, but also signals that several of its frontier-tech bets are approaching monetization.Northeast Securities: Robotics Strategy Backed by Cash Flow, Industrial ScenariosAccording to Northeast Securities, Shoucheng Holdings is the leading operator of parking infrastructure in China, having repeatedly secured high-frequency contracts for major airport parking concessions, each with annual throughput in the tens of millions. The firm’s recurring and robust cash flow from its parking and industrial real estate operations provides the financial backbone for its strategic expansion into robotics investment.As China’s robotics industry enters a critical commercialization window, Shoucheng’s unique dual-engine model—“invest with the left hand, operate with the right”—has become its second growth curve.In early 2024, Shoucheng and Beijing Guoguan jointly launched the Beijing Robotics Industry Development Investment Fund, with an initial target size of RMB 10 billion. Since then, the firm has invested—through multiple fund platforms—in top-tier robotics companies such as Unitree Robotics, DEEP Robotics, Galbot, Volant Aerotech. These companies span humanoid robots, medical robots, industrial automation, and more.What makes Shoucheng’s robotics investment strategy distinctive is its built-in industrial scenario advantage. The company operates over 100 parking facilities and manages over 1 million square meters of industrial park space across China, offering abundant real-world testing environments. This accelerates product commercialization, feeds operational data back into product iterations, and enables co-evolution between Shoucheng and its portfolio companies.In February 2025, Shoucheng formally established Beijing Shoucheng Robotics Technology Co., Ltd., further institutionalizing its industrial platform. Going forward, the conversion of in-house scenarios into actual robotics purchase orders—including deployments via REIT-backed properties and industry-specific use cases—will continue to validate this integrated approach. With its platform now connecting capital, use-case, and demand, Shoucheng is expected to sustain strong visibility in robotics commercialization going forward.As both Imunopharm and Unitree Robotics—Shoucheng Holdings’ key portfolio companies in the fields of medical and robotics technologies—progress toward IPO, the company is approaching a critical inflection point where strategic investment begins to convert into tangible capital returns.The recent share buybacks are not only a direct signal of confidence in Shoucheng’s intrinsic value, but also reflect its precise grasp of the timing for value realization.Against the backdrop of a polarized valuation landscape in Hong Kong’s equity market, Shoucheng Holdings’ continuous buyback initiative helps stabilize investor sentiment while reinforcing market expectations. With the upcoming World Robot Conference and Humanoid Robot Games set to shine a spotlight on the sector, the company is poised to benefit from a convergence of commercialization momentum and valuation recovery.From infrastructure operator to technology value enabler, from strategic organizer to capital return executor—Shoucheng Holdings’ second growth curve is now visibly unfolding.Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 ACN Newswire via SeaPRwire.com.
金嗓子：喉寶產品獲烏茲別克斯坦衛生部認證
香港，2025年7月31日 - (亞太商訊 via SeaPRwire.com) - 隨着全球化進程的持續加速，中醫藥產業在國際市場上的影響力不斷擴大。在此背景下，眾多中醫藥企業紛紛加快「出海」步伐，積極布局國際市場，全力搶占全球健康產業的戰略高地。金嗓子（6896.HK）作為中國喉片市場的領軍品牌，海外拓展再傳捷報：金嗓子喉寶產品經烏茲別克斯坦實驗室檢測報告確認，烏茲別克斯坦衛生部認定該產品具有代謝調節和免疫支持功能。這意味着，公司產品成功進入烏茲別克斯坦。這不僅是對金嗓子產品的高度認可，更是對其在海外市場發展前景的有力肯定，標誌着公司國際化布局邁出了關鍵步伐。實際上，金嗓子海外拓展的征程勢如破竹，持續加速。24年7月以來，金嗓子產品相繼亮相泰國國際保健用品展、菲律賓國際醫藥用品展、烏茲別克斯坦中國品牌展、智利聖地亞哥食品展、沙特吉達國際食品展等重要國際展會，以「東方草本」的獨特魅力吸引全球目光。經過十多年的海外市場拓展，金嗓子的全球版圖實現跨越式拓展，產品矩陣已覆蓋全球五大洲60餘個國家和地區，構建起橫跨「一帶一路」沿線與RCEP經濟圈的國際化營銷網絡，全面體現了金嗓子在海外市場的強大實力與品牌的國際影響力，隨着品牌知名度的不斷提高，其在全球市場的競爭力也將進一步增強。金嗓子產品之所以能夠在全球獲得青睞，主要得益於公司強勁的研發實力。自1994年以來，公司已成功開發32項新產品，並已就該等產品取得生產許可證。公司旗艦陣容由兩大明星系列領銜——「金嗓子喉片（OTC）」與「金嗓子喉寶」系列產品，已實現對全國藥店、商超渠道的全場景覆蓋；新一代益生元產品「金嗓子腸寶益生元」，是體內益生菌最愛的養料，能輔助腸道內的有益菌，抑制有害菌，打造腸道菌群平衡生態；「金嗓子複合益生菌含片」則攜手北京農學院食品微生物功能開發科研團隊，採用自主知識產權菌株及六項國家專利活性益生菌技術，帶來三種時尚口味，為口腔與腸道雙重守護，這六項產品均為公司「王牌」產品。此外，公司另有8款藥品、22款食品、1款保健食品及1款醫療器械產品，形成豐富產品矩陣。2025年下半年開始，金嗓子集團也將逐步重磅推出六款經典名方新藥，讓千年智慧煥發新生。並且，為進一步提升研發能力，公司研發產業化基地二期工程於2023年10月全面動工。截至2024年底，二期工程已經完成大部分地上建築結構，準備進入內部裝修階段，該基地將構建「一核三極」創新生態體系，打造集研發孵化、智能製造、學術交流於一體的健康產業創新高地，為公司未來的持續發展提供強大的技術支撐與創新動力。全球化戰略的持續推進，亦為金嗓子帶來了亮眼的財務表現。根據財報，2024年公司收益約為人民幣11.85億元，同比增長23.3%，毛利約為人民幣8.94億元，同比增長28.2%，淨利約為人民幣3.19億元，同比增長27.3%。中長期來看，隨着消費升級的持續推進以及全民健康意識的逐步覺醒，中國大健康產業將迎來蓬勃發展的黃金時期，咽喉健康市場亦將隨之持續擴容。根據中國醫藥工業信息中心預測，2023-2028年該領域複合增長率將維持在12.3%的高位，其中OTC類產品占比預計從當前58%提升至65%。金嗓子作為咽喉健康領域的頭部企業，憑藉着優異的產品質量、強大的品牌力及深遠的文化輸出戰略，有望迎來前所未有的發展機遇。展望未來，公司將進一步拓展市場份額，持續鞏固行業領先地位，力爭在全球市場上脫穎而出，為全球消費者帶來更加質量化、多樣化的大健康產品，為中國中醫藥文化的傳播和發展做出更大的貢獻。 Copyright 2025 亞太商訊 via SeaPRwire.com.
連續回購逾2000萬股 首程控股率先出手釋放強烈信號
香港，2025年7月31日 - (亞太商訊 via SeaPRwire.com) - 在港股整體估值承壓、觀望情緒濃厚之際，首程控股（0697.HK）選擇以實際行動回應市場。根據港交所公告，公司於2025年7月29日及30日連續兩日斥資3,792.93萬港元，累計回購2,065萬股股份，成交價介乎每股1.80至1.87港元。這並非公司首次大手筆出手。今年7月以來，公司已累計回購逾3,600萬股，總金額超過6,600萬港元。在多數企業仍持審慎態度之時，首程控股的密集回購行動，愈發凸顯其底氣與信心。一、回購非僅為「護盤」 更是管理層對企業價值的堅定表態股份回購一向被視為上市公司向資本市場釋放信號的重要方式。與短期性的「技術性托底」不同，首程控股的多輪主動回購，明顯建立在管理層對公司長期價值的判斷之上。公司管理層表示：「目前公司股價未能充分反映企業基本面及產業潛力，我們認為在價值嚴重低估階段，應由公司主動出手，釋放長期信心。這不僅是對股東負責的體現，更是作為一家產業型企業的責任擔當。」公開資料顯示，首程控股近年圍繞「資產營運 + 資產融通」雙輪驅動戰略，持續推進產業空間管理、公募REITs投資、智慧停車等多元業務發展，並前瞻性布局機械人與醫療科技等新興賽道，產業協同效應與資本結構日益穩健。二、IPO預期臨近 資本兌現窗口漸開近期，首程控股所投企業利好頻傳。機械人領域代表性企業宇樹科技已正式啟動科創板上市進程。作為全球領先的四足及人形機械人企業，宇樹科技的上市預期被視為行業資本化的重要拐點。首程控股於2024年領投其C輪融資，並在後續輪次中持續支持。根據公開資訊，首程控股管理的北京機器人產業發展投資基金目前為宇樹科技第八大股東，或將成為其上市的主要受益方之一。與此同時，專注於細胞治療與免疫工程的創新藥企業IMUNOPHARM亦已正式進入IPO籌備階段，為首程控股在醫療科技方向的投資組合提供重要退出渠道。隨著多個項目逐步進入「價值兌現」週期，首程控股的持續回購不僅有助提振市場信心，也反映管理層對一級資產估值與二級市場股價錯配情況的敏銳判斷。三、三場大會賦能「機械人矩陣」落地除資本層面進展外，公司在產業端的佈局亦迎來關鍵節點。7月底，2025世界人工智能大會（WAIC）圓滿落幕，首程控股旗下被投企業如宇樹科技、松延動力、墨現科技、雲深處、銀河通用等集中亮相，展示了中國智能製造及具身智能領域的最新突破。緊接着，8月即將舉行兩場重磅產業盛會：2025世界機器人大會（WRC）及首屆世界人形機械人運動會。作為行業年度核心平台，兩場大會不僅匯聚全球頭部技術與應用團隊，亦將為首程控股構建的「機械人生態」提供規模化曝光與應用落地機遇。據悉，首程控股旗下的宇樹科技、銀河通用、加速進化、松延動力、雲深處等企業將悉數參展，覆蓋從整機研發、控制系統、仿生驅動，到場景應用及開發者平台等多個細分環節，充分展示從投資佈局到產業協同的全鏈條能力。在眾多企業仍觀望市場回暖之際，首程控股已用連續回購的方式，率先向市場發出清晰信號。當回購不再僅是價格管理工具，而成為公司對未來戰略的「投票行動」，其背後所體現的判斷力、執行力與長期主義，尤為稀缺。隨着8月產業窗口期臨近，以及IPO推進與資本兌現預期升溫，首程控股的回購動作或不僅是當下價值的維穩，更是對中長期成長邏輯的提前確認。Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 亞太商訊 via SeaPRwire.com.
Early Alzheimer’s Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
- Data Showed LEQEMBI Slowed Clinical Decline by 1.75 Points on CDR-SB at Four Years Compared to the Natural History of Alzheimer’s Disease- 56% of Patients with Low Tau Continued to Demonstrate Improved Cognitive and Daily Living Function at Four YearsTOKYO and CAMBRIDGE, Mass., July 31, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”)and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher,“Biogen”) announced today that the latest findings demonstrating the benefits of continuous treatment with lecanemab-irmb (U.S. brand name: LEQEMBI®), an anti-amyloid beta (AB) protofibril* antibody for the treatment of early Alzheimer’s disease (AD), were presented at the Alzheimer's Association International Conference(AAIC) 2025, held in Toronto, Canada, and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.Four Years of Lecanemab Therapy Helped Patients Slow the Progression of AD and Remain in the Early Stages of AD Longer Compared to AD’s Natural Course Clarity AD is a global Phase 3 placebo-controlled, double-blind, parallel-group, randomized study to evaluate lecanemab 10 mg/kg bi-weekly IV treatment of early Alzheimer's disease, which involved 1,795 patients(treatment group: 898, placebo group: 897). 95% of patients who completed the core study (18 months) chose to continue in the open-label extension study (OLE), with 478 patients still receiving treatment for four years. In the Clarity AD core study, the mean change from baseline between the lecanemab treated group and the placebo group after 18 months was -0.45 (P=0.00005) on the primary endpoint of CDR-SB global cognitive and functional scale.To provide context, a change from 0.5 to 1 on the Clinical Dementia Rating (CDR) score domains of Memory, Community Affairs and Home/Hobbies reflects a shift from mild impairment to loss of independence. This can affect a person’s ability to be left alone safely, recall recent events, participate in daily activities, manage household tasks, and engage in hobbies and intellectual interests.1,2Over three years of treatment, including both the core study and the OLE, data showed lecanemab demonstrate da reduction in cognitive decline—measured by CDR-SB—of 1.01 points compared to the expected decline observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)** cohort. This benefit grew more pronounced after four years, with a reduction of 1.75 points. Similarly, when bench marked against the expected decline in the BioFINDER*** cohort, lecanemab showed a reduction of 1.40 points at three years and an even greater reduction of 2.17 points at the four years mark. For more details, please visit: https://www.eisai.com/news/2025/pdf/enews202554pdf.pdfMEDIA CONTACTSEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@Eisai.comBiogen Inc.Madeleine Shin+1-781-464-3260public.affairs@biogen.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations DepartmentTEL: +81 (0) 3-3817-5122Biogen Inc.Tim Power+ 1-781-464-2442IR@biogen.com Copyright 2025 JCN Newswire via SeaPRwire.com.
New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., July 31, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”)and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher,“Biogen”) announced today that results on investigational maintenance therapy with subcutaneous autoinjector (SCAI) of lecanemab-irmb (U.S. brand name: LEQEMBI®), an anti-amyloid beta (AB) protofibril* antibody for the treatment of early Alzheimer’s disease (AD), were presented at the Alzheimer's Association International Conference(AAIC) 2025, held in Toronto, and virtually. Only lecanemab fights AD in two ways—targeting both protofibrils and plaque, which can impact tau accumulation downstream.Importance of Ongoing Treatment and SC Development ProgramDue to the reaccumulation of AD biomarkers and return to placebo rate of decline after therapy is stopped1, Eisai is investigating a new lecanemab SC maintenance treatment option following 18 months of IV therapy so patients can continue to fight this progressive, relentless disease.Clinical trials of lecanemab SC were conducted as a sub-study of the open-label extension (OLE) following the core Phase 3 Clarity AD study in individuals with early AD, to evaluate a range of doses administered by SC vial or autoinjector. Eisai has developed a SC-AI for maintenance therapy at a dose of 360 mg weekly and a500 mg SC-AI is being developed for initiation dosing. Similar Impact on Clinical Outcomes and Biomarkers with IV and SC DosingThe pharmacology (PK/PD), clinical (efficacy endpoints such as CDR-SB) and biomarker (amyloid PET and blood biomarkers) relationships established with extensive clinical data supported the FDA approval of IV maintenance therapy after the initial 18 months of treatment and support the investigational SC maintenance dose option.- Data supports that transitioning to a weekly 360 mg SC AI dose of lecanemab after 18 months of initiation dose (10 mg/kg IV biweekly) maintains clinical and biomarker benefits comparable to continued biweekly IV dosing.- Clinical and biomarker responses at 48 months with monthly IV maintenance dosing are similar to the responses with ongoing biweekly dosing whether patients are amyloid positive (>30 CL) or negative (<30 CL) at 18 months.- Data shows the 500 mg SC AI has equivalent exposure as the initial treatment regimen of 10mg/kg IV biweekly up to 18 months for amyloid removal, efficacy, and ARIA-E.Safety MattersThe safety profile of 360 mg weekly SC maintenance dosing was shown to be consistent with that of IV maintenance therapy, with <1% systemic injection/infusion reactions. Across all SC doses, the rate of systemic injection/infusion reactions is 1% compared to 26% with IV. The 360 mg SC maintenance dose was initiated after 18 months of IV treatment, beyond the high-risk period for ARIA. There were 0 cases of ARIA-E observed out of 49 treated with 360 mg SC weekly maintenance for a mean of 6 months.Study Participants Successfully Administered SC-AI and Found it Easy to UseTo optimize the safe and effective use of SC autoinjector (SC-AI), additional studies were conducted, including a human factors (HF) study and a tolerability assessment of the device.The HF Study involved 110 participants (63 early AD patients, 32 care partners, and 15 healthcare professionals: HCPs) to assess the appropriate administration of lecanemab SC-AI. Overall, 95% (104/110) of participants successfully administered the maintenance dose. The Autoinjector Device Acceptability Study involved 126 participants (25 early AD patients, 50 care partners, and 51 HCPs), to evaluate the device's ease of use, convenience and feasibility of administration. As an interim outcome, over 95% of participants reported that the SC-AI is easy to administer. They were highly satisfied with it and had no concerns about administration, even at home. Furthermore, all patients responded that they welcomed the introduction of SC-AI.These studies and evaluations of lecanemab SC-AI have demonstrated that the investigational SC-AI offers efficacy and safety comparable to IV administration with the potential to reduce the incidence of infusion site adverse events. From the perspective of patients and care partners, benefits included the ability to use the device at home, shortening treatment time, and to continue treatment without having to worry about visiting an infusion center. From the perspective of HCPs, they reported that the device has the potential to provide a new option for patients who are benefiting from lecanemab to continue the treatment. The SC formulation has the potential to reduce medical preparation and administration time related to IV therapy. These factors suggest that the SC AI may play an important role in continuing treatment for early AD.This release is based on the content of the presentations given at AAIC, "Featured Research Session #4-13-FRS-C: Lecanemab Subcutaneous Formulation for Maintenance Dosing: The Potential of a New and Convenient Option for Ongoing Treatment in Early Alzheimer’s Disease," held at 9:00 AM on Wednesday, July 30, and also includes some content from the Developing Topics session held at 8:00 AM on Sunday, July 27,entitled "Patient, Care Partner, and Health Care Professional Opinion of the Lecanemab Autoinjector for Subcutaneous Delivery in Early Alzheimer's Disease Patients."Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority.* Protofibrils are thought to be the most toxic AB species that contribute to brain damage in AD and play a major role in the cognitive decline of this progressive and devastating disease. Protofibrils can cause neuronal and synaptic damage in the brain, which can subsequently adversely affect cognitive function through multiple mechanisms.1 The mechanism by which this occurs has been reported not only by increasing the formation of insoluble AB plaques, but also by directly damaging signaling between neurons and other cells. It is believed that reducing protofibrils may reduce neuronal damage and cognitive impairment, potentially preventing the progression of AD. 2For more details, please visit: https://www.eisai.com/news/2025/pdf/enews202553pdf.pdfMEDIA CONTACTSEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@Eisai.comBiogen Inc.Madeleine Shin+1-781-464-3260public.affairs@biogen.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations DepartmentTEL: +81 (0) 3-3817-5122Biogen Inc.Tim Power+ 1-781-464-2442IR@biogen.com Copyright 2025 JCN Newswire via SeaPRwire.com.
Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025
TOKYO and CAMBRIDGE, Mass., July 31, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito,“Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A.Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-AB protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways– targeting both amyloid plaque and protofibrils*, which can impact tau downstream.Lecanemab received traditional approval in the U.S. in July 2023 for the treatment of early Alzheimer's disease (AD). This retrospective study was conducted to investigate the actual state of real-world clinical treatment with lecanemabat 15 medical centers in the U.S., with a final report scheduled for late in the third quarter of Eisai’s fiscal year ending March 31, 2026. This presentation serves as an interim report as of July 1, 2025.Patient Baseline and Actual Treatment Situation The interim study collected information on 178 people living with early AD from nine US medical centers using a standardized case report format. The disease stage of the patients at baseline was mild cognitive impairment (MCI) due to AD in 57.6% and mild AD in 42.4%. The average age of the patients was 74.2 (±6.6) years, and the ratio of men to women was 44.6 to 55.4.The mean duration of lecanemab treatment was 375.4 days (± 182.8 days). The mean time from diagnosis to first treatment was 224.2 days (± 295.4 days) and the mean number of lecanemab treatments was 24.8 (± 11.5). At the time of case reporting, 87.4% of patients (152 patients) were continuing treatment with lecanemab. Adverse events leading to discontinuation of treatment included ARIA-E (ARIA-edema/exudation) in two patients (1.1%), ARIA-H(ARIA-cerebral microbleeds, cerebral hemorrhage and superficial hemosiderin deposition) in two patients (1.1%),and concomitant ARIA-E and ARIA-H in one patient (0.6%). Three patients (1.7%) discontinued due to adverse events other than ARIA. In addition, 11 patients (6.3%) reported discontinuing the treatment for personal reasons or at the discretion of their doctor or the individual.In this study, 83.6% of patients either remained at the same clinical stage or improved from mild dementia to MCI (stable: 76.9%, improvement: 6.7%). Additionally, at time of interim data cut, 86.7% of patients who had received 40 or more doses over 18 months remained stable or showed clinical improvement (stable: 66.7%,improvement: 20.0%:).Of the 178 patients, ARIA was observed in 23 (12.9%). 14 (7.9%) were observed to have ARIA-E, of which 12(6.7%) were asymptomatic. ARIA-H was present in 11 patients (6.2%), all of whom were asymptomatic. Infusion reactions were observed in four patients (2.2%). Additionally, no serious bleeding events or deaths were reported. Impact of APOE4 Status Of the 178 patients in this study, 12 were excluded with unknown status. Among the remaining 166 patients,30 (18.1%) were APOE 4 homozygotes, 84 (49.4%) were heterozygotes, 54 (32.5%) were non-carriers. Generally, the proportion of homozygotes among people with AD is thought to be 15% or more.The incidence of ARIA was 20.0%, 9.8% and 14.8% in homozygous carriers, heterozygous carriers and noncarriers, respectively (45.0%, 19.0% and 13.0% respectively in the Phase 3 Clarity AD 18-month core study). The incidence rate of ARIA-E and ARIA-H were 13.3% and 10.0%, respectively (32.6% and 39.0% in the Clarity AD core study), which is within the FDA-approved label range. The majority of ARIA cases (0.13%) were asymptomatic. The incidence of adverse events leading to discontinuation was 16.7% in homozygous carriers,2.4% in heterozygous carriers and 5.6% in non-carriers.73.3% of homozygote patients’ clinical stage remained stable or improved (stable: 66.6%, improved: 6.7%),88.0% of heterozygotes patients’ clinical stage remained stable or improved (stable: 83.0%, improved: 4.9%)and 85.2% of non-carrier patients’ clinical stage remained stable or improved (stable: 75.9%, improved: 9.3%).Utilization of Blood-Based Biomarkers (BBMs)BBMs are being developed in AD to identify brain AB pathology and are intended for use in prescreening (triage)and confirmatory diagnosis. Of the 178 patients in this study, 49 patients (27.5%) were diagnosed using BBMs. In some of these cases (11 patients, 6.1%), it was also used for confirmatory diagnosis. Data collected from clinical practices showed the volume of tests doubling every 4 to 8 months, with BBMs using p-tau217 growing most rapidly.Satisfaction with Lecanemab Treatment The results of a physician, patient and care partner lecanemab satisfaction survey was presented. The survey was based on questionnaires and interviews with nine U.S. physicians and evaluated treatment from multiple perspectives, including efficacy, safety and quality of life (QOL).In the physicians’ evaluation, the average satisfaction level for the treatment efficacy and safety (out of 10) was8.7. The scoring criteria included: cognition 8.1, daily function 8.1, behavioral/neuropsychiatric symptoms 7.9and QOL 8.0. The satisfaction level of the patients as assessed by physicians was 8.8, and that of the care partners was 8.2. These results highlight the favorable evaluation of lecanemab’s efficacy and safety in real world clinical practice and reinforce its therapeutic value.Note: Retrospective real-world studies can be very valuable in providing additional information to complement clinical trial data. However, there may have several limitations to keep in mind:Potential for BiasesData Completeness and ConsistencyData may be collected inconsistently since data collection is completed by different people at independent3 sites.* Mitigation: Data inconsistency is pursued by providing site access to standardized electronic case-report forms.Lack of Control GroupInterpretation of data may be limited since real-world studies do not utilize placebo-controlled armsConfounding VariablesConfounding variables are not controllable, which may impact the relationship between the exposure and outcome.Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority.* Protofibrils are thought to be the most toxic AB species that contribute to brain damage in AD and play a major role in the cognitive decline of this progressive and devastating disease. Protofibrils can cause neuronal and synaptic damage in the brain, which can subsequently adversely affect cognitive function through multiple mechanisms.1 The mechanism by which this occurs has been reported not only by increasing the formation of insoluble AB plaques, but also by directly damaging signaling between neurons and other cells. It is believed that reducing protofibrils may reduce neuronal damage and cognitive impairment, potentially preventing the progression of AD.2For more details, please visit: https://www.eisai.com/news/2025/pdf/enews202552pdf.pdfMEDIA CONTACTSEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@Eisai.comBiogen Inc.Madeleine Shin+1-781-464-3260public.affairs@biogen.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations DepartmentTEL: +81 (0) 3-3817-5122Biogen Inc.Tim Power+ 1-781-464-2442IR@biogen.com Copyright 2025 JCN Newswire via SeaPRwire.com.
冠君產業信託三度舉辦ESG主題盛會 創新定義商廈價值與可持續未來
香港，2025年7月30日 - (亞太商訊 via SeaPRwire.com) - 持有花園道三號及朗豪坊物業的冠君產業信託（股份代號：2778）欣然宣佈，第三屆 ESG 主題活動「ESG Gala」已正式開幕，活動於7月29日至8月1日期間舉辦。延續過去兩屆備受好評的ESG論壇，今年活動全面升級，不論規模或內容均更臻完善，全面展現其在可持續發展領域的承諾與實踐。作為積極推動 ESG 的企業，信託以前瞻視野重新定義商廈營運的角色與其商業價值。今年的「ESG Gala」以「創新-啟發-融合」為主題，全方位推動產業升級，進一步鞏固其在地產行業的領導地位。從資產營運管理邁向價值共創的「超級增值人」信託跳出傳統資產管理角色的框架，積極透過跨界別合作與知識共享，打造以ESG為核心、租戶共創的協同平台，並成功連結逾500個租戶和合作伙伴，攜手實踐綠色營運與共融文化，創造多贏局面。- ESG主題活動與影響力：連續三年舉辦ESG主題活動，成功整合跨產業資源，吸引來自金融、零售、餐飲、美容等界別的租戶參與，累計參與人次突破50,000，進一步擴展規模與深化影響力，為持份者創造可持續的增值效益。- 智能科技減碳成果：積極應用創新科技，於花園道三號成功引入人工智能（AI）製冷機組優化程序，結合智能氣象站，準確預測冷卻負載，進一步降低能源消耗與碳排放。- 租戶綠色轉型實踐：「綠『惜』環保約章」自2024年10月起由辦公室租戶拓展至零售租戶，參與企業包括貝萊德資產管理北亞有限公司、花旗集團、工銀國際控股有限公司、LSEG、Adidas、株式會社有限公司、perFACE等，計劃成效顯著：80%參與租戶已制定能源使用目標100%參與租戶落實至少三類廢物回收能源使用強度在半年内較去年平均下降6%[1]年内舉辦了三場綠色工作坊與導賞團，參與人次突破100人對接香港政策 推動綠色創科與智慧城市發展信託積極響應特區政府推動創科發展及《香港智慧城市藍圖》政策方針，不僅提升自身ESG表現，更有效串連整個價值鏈的轉型，將可持續發展效益擴大化，為租戶及投資者創造更大價值。信託致力運用創新科技與智能數據系統，全面提升資源使用效率與環境監測能力，為租戶建立更智能、可持續的營商環境，創造長遠價值；與此同時，信託積極開拓可持續金融機遇，透過可持續發展掛鈎貸款等工具，進一步強化綠色金融實力。科技賦能可持續發展 引領健康生活新模式信託不僅致力於創新科技應用，更關注大眾身心靈健康，是次活動涵蓋健康生活元素。開幕首日，信託邀請到曾三度出征奧運並屢破香港紀錄的泳將鄭莉梅（Camille Cheng），分享運動員視角下的身心健康與韌性。信託更邀請到初創平台Intellect團隊分享科技如何革新企業員工的身心健康，同時將攜手PURE Fitness舉辦運動體驗日，設立智能健康檢測專區，讓租戶親身體驗嶄新的健康管理方案。此外，信託旗下朗豪坊辦公樓引領業界，打造結合六大健康維度的「6 Dimensions Wellness」創新概念，除了開設專屬YouTube頻道(@6dwellnesslp)，更於Eaton Club推出Social Wellness Hall，整合線上線下平台，全方位促進都市健康生活。ESG Gala活動期間特別規劃專題日，透過行業論壇、運動工作坊等多元活動形式，匯聚業界專才共同探討身心靈健康新維度。「6D Wellness Hub」於朗豪坊辦公樓隆重揭幕，邀請了藝人張繼聰及國際知名風景攝影師袁斯樂（Kelvin Yuen）擔任啟動嘉賓。張繼聰於活動中分享提升健康的心得，並預告將於6D Wellness YouTube頻道分享智能健康與家庭幸福之道。同時，攝影師袁斯樂（Kelvin Yuen）為其作品及學生攝影比賽揭幕，激發青年潛能與多元創意。青年與共融 啟發未來可持續領袖我們亦舉辦青年藝術導賞，邀請大學生參觀藝術展覽並體驗互動室內運動。此外，信託響應香港政府「共創明『Teen』計劃」，將於8月1日在朗豪坊包場舉辦電影放映會，並邀請本地動畫師崔氏兄弟分享職涯規劃，鼓勵青少年探索多元職涯發展。活動更特別設立藝術展區，與致力協助自閉症群體的「愛-傳遞」機構共同策劃「共融色彩：子舜眼中的香港」主題畫展，於7月29日至8月8日期間在花園道三號展出自閉症青年藝術家李子舜的畫作，透過藝術展現多元共融價值。冠君產業信託行政總裁侯迅女士表示：「多年來，我們成功突破傳統框架，建立了強大的戰略合作網絡與資源，從傳統資產管理人轉型為業界的『超級聯繫人』，更進一步躍升為『超級增值人』。透過創新科技與策略合作，連結更多持份者、促進協同效應。在邁向可持續未來的道路上，科技創新與人文關懷相輔相成，我們的 ESG Gala 正好體現這一理念，展示如何將創新科技應用於提升身心健康、啟發新一代，以及推動社會共融。信託不僅是資產管理人，更是價值共創的推動者，致力為香港構建一個更智能、更綠色、更共融的未來智慧城市。」三屆香港奧運游泳代表、Mind The Waves 聯合創辦人鄭莉梅女士表示：「作為一名運動員，我深刻體會身心健康是持續突破的關鍵。無論是運動挑戰，或是人生的逆境考驗，真正的韌性不僅在於堅持，更是在低谷中學會自我調整、重新出發。我深切理解香港年青人面對的精神壓力，很高興能參與『ESG Gala』，分享運動員的心路歷程，鼓勵年青一代在這個迅速變化的社會中，學會關愛自己，正視身心靈健康，勇敢活出自我價值。」「愛-傳遞」創會主席潘嘉麗女士表示：「今次很感恩能與信託合作舉辦畫展，讓自閉症青年畫家李子舜的作品得以展示，意義深遠。這次合作不僅展現了子舜的藝術才華，更是推動社會對特殊教育群體的理解與接納的重要一步。透過藝術，我們能夠打破隔膜，促進包容。」附錄一：「綠『惜』環保約章」參與企業花園道三號1貝萊德資產管理北亞有限公司2花旗集團3CMC Capital Partners HK Limited4Eaton Club5復星國際有限公司6復星財富國際控股有限公司7華金金融（國際）控股有限公司8工銀國際控股有限公司9堅信物業管理服務有限公司-花園道三號管理處10LSEG11德事商務中心朗豪坊辦公大樓12蓬生有限公司13鷹君市務管理(冠君)有限公司14Eaton Club朗豪坊商場16Adidas Hong Kong Ltd17Thai Chill18貝玲妃19安樂影片有限公司20雅慶國際有限公司21株式會社有限公司22樂高23小豬糖果店24S A Accessories25Sabon26咖啡學研27超休閑* 按英文字母序圖片說明：冠君產業信託舉辦ESG Gala， 透過跨界別合作與知識共享，攜手實踐綠色營運與共融文化資深ESG從業者參與綠色轉型專題一眾租戶在侯迅女士及一眾嘉賓的見證下參與「綠『惜』環保約章」典禮三屆香港奧運游泳代表、Mind The Waves 聯合創辦人鄭莉梅女士鼓勵年青一代學會關愛自己，勇敢活出自我價值關於冠君產業信託（股份代號：2778）冠君產業信託擁有及投資提供租金收入的寫字樓及零售物業。信託主要投資位於優越地點的甲級商用物業。現時擁有花園道三號及朗豪坊兩幢位於香港的地標性物業，並以合資股權形式擁有位於倫敦市中心的 66 Shoe Lane，總樓面面積約300 萬平方呎，讓投資者可直接投資於優質甲級寫字樓及零售物業。信託自2023年榮獲全球房地產GRESB可持續的最高五星級別。冠君產業信託管理人乃鷹君資產管理（冠君）有限公司，為鷹君集團的成員。網站: www.championreit.com[1] 上述資料基於參與第三階段計劃的租戶所提交的能源使用資料分析得出 Copyright 2025 亞太商訊 via SeaPRwire.com.
Sales, Production, and Export Results for the First Half of 2025
TOYOTA CITY, July 30, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation announces its sales, production, and export results for June 2025 as well as the cumulative total from January to June 2025, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd.For more details, please see the link below (detailed data).Click here for detailed sales, production, and export results ("Detailed data (Excel)")URL https://global.toyota/en/company/profile/production-sales-figures/202506.html Copyright 2025 JCN Newswire via SeaPRwire.com.
警察和法院正在轉向人工智慧，系統準備好了嗎？ “`
(SeaPRwire) - 人工智慧能否讓刑事司法系統更公平、更有效率？還是只會加強有害的偏見？ 專家表示，到目前為止，人工智慧的部署方式令人擔憂，但它具有產生正面影響的潛力。 如今，人工智慧技術幾乎已深入刑事司法系統的各個層面。 它被用於人臉識別系統以識別嫌疑人； 用於「預測性警務」策略以制定巡邏路線； 在法庭上協助案件管理； 並由公設辯護人篩選證據。 但儘管倡導者指出效率和公平性有所提高，但批評者對隱私和問責制提出了嚴重的質疑。 上個月，刑事司法委員會 (Council on Criminal Justice) 啟動了一項無黨派的人工智慧專案，以研究如何安全且合乎道德地在刑事司法系統中使用人工智慧。 該小組的工作將得到 RAND 研究人員的支持，他們最終將採用他們的研究結果並向決策者和執法部門提出建議。 「毫無疑問，人工智慧會產生不公正的結果，」工作組主席、前德克薩斯州最高法院首席法官 Nathan Hecht 說。 「這個工作組希望匯集科技人士、刑事司法人士、社群人士、各個不同領域的專家，真正坐下來看看如何利用它來改善系統，而不是造成它可能造成的危害。」 人工智慧在執法中的風險 Hecht 說，許多法院和警察部門已經在使用人工智慧。 「這是非常零散的：好奇的人會說，『哇，這裡有人工智慧，我們可以在刑事法庭上使用它。』」 但由於部署人工智慧的方式幾乎沒有標準，因此公民權利監督機構越來越擔心執法機構以危險的方式使用它。 數千個機構已經開始依賴像 Clearview 這樣的公司銷售的人臉識別技術，該公司擁有多達數十億張從互聯網上抓取的圖像的資料庫。 在許多資料庫中，黑人人口過多，部分原因是他們居住在警察過度執法的社區。 人工智慧技術也不擅長辨別黑人面孔的差異，這可能會導致更高的誤識別率。 去年，法律非營利組織 Innocence Project 表示，至少發生了七起因人臉識別技術而造成的錯誤逮捕事件，其中六起涉及被錯誤指控的黑人。 該組織的政策主管 Walter Katz 說，警察有時僅根據人工智慧的人臉識別結果進行逮捕，而不是讓人工智慧作為更大規模調查的起點。 「人們過於依賴人工智慧的輸出，」他說。 Katz 說，去年秋天他參加一個警務會議時，「到處都是人工智慧」。 供應商積極兜售聲稱可以解決警察部門實際問題的技術工具。 「但在提出這個建議時，很少關注任何權衡或風險，」他說。 例如，批評人士擔心，許多這些人工智慧工具會增加對公共空間的監控，包括監控和平抗議者，或者所謂的預測性警務將加強執法部門對警察過度執法地區的鎮壓。 人工智慧可以在哪些方面提供幫助 然而，Katz 承認人工智慧在刑事司法系統中確實佔有一席之地。 「很難擺脫人工智慧，而且在某些地方，人工智慧可以提供幫助，」他說。 因此，他加入了刑事司法委員會的人工智慧工作組。 「首先也是最重要的是了解採用的速度有多快。 如果每個人都理解完全沒有政策可能是錯誤的做法，那麼我們就從那裡開始。」 工作組主席 Hecht 認為，人工智慧可以在法庭上提供幫助的幾個領域，例如，改進被捕人員的接納流程，或幫助確定誰有資格參加轉移計劃，這些計劃允許罪犯避免被定罪。 他還希望工作組能夠就哪些類型的人工智慧使用明確不應在刑事司法中獲得批准提出建議，並採取措施保護公眾的隱私。 「我們想盡力收集必要的專業知識，以向產品的使用者和公眾保證，這將改善您在刑事司法系統中的體驗，並且之後它不會再打擾您，」他說。 與此同時，許多其他獨立的努力正在嘗試使用人工智慧來改善司法程序。 新創公司 JusticeText 希望利用人工智慧來縮小檢察官和公設辯護人之間的資源差距，後者通常人手嚴重不足且資源不足。 JusticeText 為公設辯護人構建了一個工具，可以篩選數小時的 911 呼叫、警察隨身攝影機錄像和錄音審訊，以便對其進行分析並確定，例如，警察是否發表了不一致的聲明或提出了誘導性問題。 創始人兼執行長 Devshi Mehrotra 說：「我們真的想看看首先成為公設辯護人是什麼樣子，並嘗試在過去幾年中技術在許多方面加劇的公平競爭環境。」 JusticeText 正在與全國各地約 75 個公設辯護機構合作。 刑事司法改革非營利組織 Recidiviz 也在測試幾種將人工智慧整合到其工作流程中的方法，包括向假釋官提供人工智慧生成的客戶摘要。 Recidiviz 的共同創始人 Andrew Warren 說：「您可能有 80 頁關於這個人的案件記錄，可以追溯到七年前，如果您有 150 人的案件量，並且您必須每月與每個人見面，您是不會讀這些記錄的。」 「人工智慧可以非常簡潔地突出這個人已經取得的成就以及他們可以在哪些方面獲得支持。」 那麼，決策者和刑事司法委員會工作組面臨的挑戰是確定如何制定標準和監督機制，以便人工智慧提高效率的優點超過其放大現有偏見的能力。 工作組的 Hecht 也希望防止未來黑盒人工智慧自行做出改變人生的決定。 「我們是否應該確保我們對人類正義的傳統觀念得到保護？ 當然。 我們是否應該確保有能力的法官和刑事司法系統的處理者完全控制局面？ 當然，」他說。 「但是說我們要讓人工智慧遠離司法系統是沒有希望的。 律師事務所正在使用它。 民事司法系統正在使用它。 它將會持續存在。」本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 ```
俄羅斯歷史性地震後，海嘯已襲擊這些地方
(SeaPRwire) - 這次的 引發了數英尺高的海浪，正衝向世界各地的沿海地區。 太平洋及其周邊的國家/地區已處於不同程度的 海嘯警報之中。 雖然現在要完全評估這場自然災害的破壞程度還為時過早，但當局通常建議高風險地區的居民尋找更高的地勢並避開海岸線。 以下是自這次歷史性地震以來，遭受海嘯襲擊的國家/地區。 俄羅斯 在俄羅斯，地震於當地時間週三上午 8:25 左右（美國東部時間週二下午 4:25）發生，3-4 公尺（10-13 英尺）的海嘯襲擊了遠東海岸的塞維羅-庫里爾斯克港口城鎮。大約 2,000 人的城鎮被疏散。 拍攝到的 畫面顯示，海浪到達海岸時，建築物被淹沒。據國營新聞社 報導，市長表示，有三波海浪襲擊了該鎮，最後一波最強大。俄羅斯緊急情況部在 Telegram 上表示，除了港口城鎮外，阿拉伊德魚類加工廠也「部分被淹」。 Eyewitness footage captured the moment a tsunami hit a Russian town, following a magnitude 8.8 earthquake off the country’s far eastern Kamchatka Peninsula — Reuters (@Reuters) 日本 週三當地時間上午 9:40（美國東部時間週二晚上 8:40），日本氣象廳發布了該國太平洋沿岸高達 3 公尺的海嘯警報。截至當地時間下午 5 點，該機構已觀察到 沿著該國東海岸，包括下午 2 點前不久（美國東部時間凌晨 1 點）在久慈港出現的浪高達 1.3 公尺的海浪。 此前，30 公分高的海浪襲擊了北海道北部多個地區。 路透社分享的影片顯示，巨浪到達了該島的海岸線。 Huge waves reached the coastline of Hokkaido in Japan after a magnitude 8.8 earthquake struck off Russia's Far Eastern Kamchatka Peninsula — Reuters (@Reuters) 到目前為止，尚未有海嘯相關損害的報告，但公共廣播公司 NHK 報導稱，東京當局繼續建議人們避開大海。該國的一些海灘也已被疏散。 據 NHK 報導，JMA 官員清元正志表示，單一海嘯可能有一個非常長的週期，約為一小時，並且在引發海嘯的地震發生後，海嘯仍然可以在更長的時間內被觀察到。 美國 阿拉斯加 根據 的說法，在阿拉斯加半島面向太平洋的一側檢測到海嘯。在阿姆奇特卡島和阿達克島檢測到不到一英尺高的海浪，並且在聖保羅沿海城市也在增強。 加利福尼亞 加利福尼亞州在太平洋時間凌晨 1 點（美國東部時間凌晨 4 點）後不久報告了第一次海嘯。 美國國家海洋暨大氣總署 (NOAA) 的 數據顯示，克雷森特城（位於加利福尼亞州北部，靠近俄勒岡州）的水位上升至 1.5 英尺。 NWS Bay Area 報告說，大約在同一時間，海嘯 也在同一時間出現，而 NWS Los Angeles 表示，海嘯是「不重要的」，儘管它之前曾指出南加州居民「預計不會發生大範圍的淹沒」。 關島 據 稱，在太平洋的美國領土關島，已經觀察到高達一英尺的海浪。預計會出現更多類似高度的海浪，儘管預計它們將在接下來的幾個小時內逐漸消退。 夏威夷 根據 NOAA 的 數據顯示，群島州夏威夷大約在夏威夷標準時間晚上 7:30（美國東部時間凌晨 1:30）開始遭受海浪襲擊，數據顯示在茂宜島的卡胡魯伊檢測到高達 5.7 英尺（1.74 公尺）的海浪，間隔為 34 分鐘。 州長 Josh Green 在 中表示，「到目前為止，我們還沒有看到任何重大的海浪，這讓我們感到非常欣慰。」 來自位於日本和夏威夷之間的中途島環礁的數據顯示，海浪高達 1.8 公尺，Green 說，襲擊夏威夷的海浪可能比這更大或更小。 Green 在晚上 8:30 左右（美國東部時間凌晨 2:30）說：「我們預計至少要等兩到三個小時才能宣布『解除警報』。」 「不過到目前為止，一切都很好。」本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 ```
海嘯期間如何確保安全
(SeaPRwire) - 在俄羅斯東部發生世界第六大地震後，十幾個國家正處於潛在海嘯活動的警戒狀態。 週三上午襲擊俄羅斯堪察加半島的8.8級地震已經導致第一波海嘯抵達日本的北海道海岸，而夏威夷的居民已被建議在海嘯警報聲中轉移到地勢較高的地區。西海岸的大部分地區、阿拉斯加和太平洋地區的國家也收到了不同程度的海嘯警報。 以下是在發生海嘯時需要了解的事項。 什麼是海嘯？ 根據美國國家氣象局的說法，海嘯是由地震或海底火山爆發引起的一系列巨大海浪。地震活動會導致突然的海洋水域位移，從而產生強勁的水流和強大的海浪，這些海浪在接近海岸時高度會增加。 海浪向四面八方輻射，並且可以在深水中以噴射機的速度行進，而在到達較淺的深度時則會減速。 海嘯由多個海浪組成，這些海浪可以在一段較長的時間內發生。第一波浪並不總是最大的，隨後的海浪可能會突然且顯著地增加高度。大型海嘯也可能持續數天。日本表示，堪察加地震引起的海嘯可能會持續一天以上。 如何預測海嘯？ 儘管一些國家已經發布了海嘯預報，但這次地震產生的每次海嘯的嚴重程度可能會有所不同。襲擊俄羅斯港口城市Severo-Kurilsk的海浪高度為10-13英尺（3-4米），而襲擊日本北海道海岸的海浪高度約為12英寸（30厘米）至16英寸（40厘米）。 根據美國國家氣象局的說法，海嘯也無法精確預測。相反，海嘯預警中心會根據先前的地震的大小和位置來預測海嘯，並使用預測模型來估算海嘯一旦被檢測到後的海浪高度、位置和到達時間。 美國國家海洋和大氣管理局 (NOAA) 與更廣泛的國際系統網絡合作，使用深海評估和報告海嘯 (DART) 浮標，通過測量海嘯波通過時水壓的變化來實時檢測、測量和報告公海中的海嘯。 海嘯警報時該怎麼辦 美國遵循四級海嘯警報系統。根據美國國家氣象局的說法，按嚴重程度降序排列，這些警報是：警告、諮詢、觀察和信息聲明。 人們也應該警惕海嘯的明顯自然跡象，包括來自海洋的巨大轟鳴聲以及水位的突然上升或下降。海岸線水位的突然退卻表明可能發生海嘯。 海嘯警告是海嘯的最高警報。NWS表示，海嘯警告意味著：「採取行動—危險！預計或正在發生可能導致大範圍洪水的海嘯。危險的沿海洪水和強大的水流是可能的，並且可能在最初到達後持續數小時或數天。」 在發生海嘯警告時，建議人們立即撤離並轉移到高地，並盡可能向內陸移動（至少高於海平面100英尺或內陸一英里），並聽從地方當局的指示。一些受到威脅的地區，例如檀香山，也為撤離人員開放緊急避難所。 儘管人們應該轉移到高地，但根據NWS的說法，大多數高層建築並非旨在承受海嘯的衝擊。如果沒有其他選擇，一些高大而堅固的建築物的較高樓層可能會提供一些保護。 美國國土安全部表示，如果您在發布海嘯警告時在海上的一艘船上，您應該出海到安全的深度。如果您在港口中，則應離開您的船隻並轉移到陸地上的一個安全區域。 海嘯諮詢時該怎麼辦 海嘯諮詢是NWS發布的第二高警報級別。該機構表示，海嘯諮詢意味著：「採取行動—預計或正在發生海嘯，該海嘯有可能產生強勁的水流或對水中或非常靠近水域的人造成危險的海浪。海灘和港口區域可能會發生洪水。」 建議人們遠離水域，遠離海灘和水道，並聽從地方當局的指示。 其他海嘯警報意味著什麼 根據NWS的說法，海嘯觀察意味著：「做好準備—發生了遙遠的地震。可能發生海嘯。」如果發布海嘯觀察，建議人們保持警惕以獲取更多信息，並做好在必要時採取行動的準備。 海嘯信息聲明是最低的警報級別，意味著：「放鬆—發生了地震，但沒有威脅，或者地震非常遙遠，並且尚未確定威脅。在大多數情況下，沒有破壞性海嘯的威脅。」 對於太平洋和加勒比海地區的國際合作夥伴，美國發布海嘯威脅而不是警報。威脅信息根據NWS概述了對人員、結構和生態系統的潛在影響。然後，其他國家/地區確定要發布的警報。 其他國家/地區也經常使用分級警報系統，儘管它們可能對每個警報使用不同的術語。人們應該查看其當地的應急管理系統以獲取任何警報和指示。有關來自不同海嘯預警系統的更多信息，請訪問Tsunami.gov或參考您當地的氣象或應急管理中心，例如美國國家氣象局和Ready.gov。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 ```
Hong Kong Shopping Festival Returns in August with Bigger and Better 2nd Edition
- The HKTDC returns with the second Hong Kong Shopping Festival in August, building on the initiatives in the 2024 Policy Address to help local SMEs expand into the Mainland China market through e-commerce channels- The Hong Kong Shopping Festival is the flagship event of the E-commerce Express, and has received an enthusiastic response, attracting nearly 260 brands presented by Hong Kong SMEs across seven major categories, providing them with practical opportunities to operate on key e-commerce platforms in the mainland- Fully supported by the Hong Kong Special Administrative Region (HKSAR) Government, Financial Secretary of the HKSAR Government Paul Chan filmed a promotional video for the Hong Kong Shopping Festival.HONG KONG, July 30, 2025 - (ACN Newswire via SeaPRwire.com) - The second Hong Kong Shopping Festival, organised by the Hong Kong Trade Development Council (HKTDC) will take place on Mainland e-commerce platforms from 1 to 31 August. Fully aligned with measures outlined in the 2024 Policy Address, the festival aims to support Hong Kong's small and medium-sized enterprises (SMEs) as they expand into the Mainland e-commerce market. As the flagship event of HKTDC's E-commerce Express, the Hong Kong Shopping Festival has attracted nearly 260 brands across seven major categories, including health supplements, food and beverages, home and living, personal care and cosmetics, apparel and accessories, smart gadgets, and products for the silver market. The festival features over 500 unique products and offers month-long discount promotions. With the full support of the Government of the Hong Kong Special Administrative Region (HKSAR), a launch ceremony for the second Hong Kong Shopping Festival was held today. The Financial Secretary of the HKSAR Government Paul Chan also filmed a promotional video for the campaign (video link: https://bit.ly/4mkvpec). Algernon Yau, Secretary for Commerce and Economic Development of the HKSAR Government said: “Building on the great success of the first edition of the Hong Kong Shopping Festival last year, this year’s event has attracted even more brands to participate. E-commerce is a major global trend in retail development. In 2024, the cross-border e-commerce market of the Mainland with vast potential reached over RMB17 trillion, presenting a golden opportunity for Hong Kong businesses to expand. In light of this, the government has been fully supporting industry upgrading and transformation through various measures to help enterprises establish online sales channels. The Hong Kong Shopping Festival serves as an ideal platform to showcase the city's premium products to more Mainland consumers."Patrick Lau, Deputy Executive Director, HKTDC, said: “New consumer trends are emerging in the Mainland market, reshaping buying habits and creating tremendous opportunities for Hong Kong businesses. While Hong Kong SMEs offer high-quality products, they need to understand the local business environment and e-commerce practices to successfully enter this vast market. As the flagship event of HKTDC's E-commerce Express, the second Hong Kong Shopping Festival will partner with major e-commerce and social media platforms for promotion and include a series of training sessions focused on the Mainland e-commerce market. This initiative aims to help businesses effectively tap into opportunities in Mainland e-commerce and connect with their target customers.”In November 2024, the Hong Kong Trade Development Council (HKTDC) released a research study on the development of cross-border e-commerce for Hong Kong traders. HKTDC Director of Research, Irina Fan, said over 60% of surveyed Hong Kong businesses view the Mainland Chinese market as the most promising e-commerce market in the coming one to two years. To help Hong Kong businesses gain insights into the Mainland e-commerce market, HKTDC Research interviewed 2,200 Mainland consumers from different regions about their online shopping behavior and characteristics. Ms Fan said: “Mainland China is the world’s largest e-commerce market and has a well-developed e-commerce industry. Hong Kong businesses must gain a deep understanding of Mainland consumers’ online shopping behaviors, their preferences for Hong Kong products, and the factors they consider when choosing e-commerce platforms. Only then can they formulate appropriate business strategies and effectively capture opportunities in the Mainland e-commerce retail market.” The latest research report: Hong Kong Businesses Navigating Mainland China E-commerce Retail Market - Consumer Survey Results will be released on 7 August 2025.The Hong Kong Shopping Festival aims to help Hong Kong businesses take advantage of the large customer base and traffic on Mainland e-commerce platforms, boosting their brand and product visibility while providing practical opportunities. Last year's inaugural edition was very successful, with total views on e-commerce platforms, social media, and the event's official website exceeding 90 million. This year, the HKTDC has enhanced the programme, enabling businesses to better seize market opportunities and speed up their expansion into the Mainland market.To enhance support for Hong Kong SMEs and local brands entering the Mainland e-commerce market, this year's Hong Kong Shopping Festival has introduced thematic seminars and one-on-one consultancy services. From late 2024 to June 2025, HKTDC has successfully organised a series of training sessions led by marketing experts, who shared practical insights on topics such as cross-border e-commerce, logistics, payment tools, marketing skills, and live-stream production. Additionally, nearly 50 one-on-one consulting meetings were held, where Mainland marketing experts offered tailored e-commerce strategies to individual participating companies based on the unique characteristics of their products.This year, Discount Month and live-streaming e-commerce will return with enhanced offering. Discount Month will take place from 1 to 31 August, with all Hong Kong businesses involved in the Hong Kong Shopping Festival offering discounts of up to 75%. This initiative not only helps businesses grow but also allows consumers to buy high-quality products from Hong Kong online. The official website of Hong Kong Shopping Festival will provide event details, live-streaming schedules and information about participating brands, products and discounts. In addition, HKTDC will promote the campaign through online and offline platforms, including Xiaohongshu, Douyin, Taobao, JD and others, to boost visits to the official website and, redirect them to the SMEs’ online stores.HKTDC recently hosted the debut “Product Selection Showcase” which attracted over 40 popular KOLs and their teams from platforms like Taobao, JD.com, and Douyin to connect with participating brands offline in Hong Kong. They experienced the products firsthand, learned about the brand stories, shared highlights and live-stream previews. In early August, HKTDC’s invited Mainland key opinion leaders (KOLs), including Li Jiaqi, Lin Yilun and Hu Ke, will conduct 35 live-streaming sessions for more than 80 brands on major e-commerce platforms, in which nearly 20 live-streaming sessions will take place in Hong Kong for the first time, allowing Mainland consumers to fully experience shopping in Hong Kong. This arrangement will make live-streaming more appealing, enhance visibility for Hong Kong products and brands, and build consumer trust and interest, while providing a valuable live-streaming experience for participating businesses.Mainland online marketing strategies are diverse and multifaceted. Beyond live-streaming, there are numerous ways to enhance brand exposure. Ryan Tse, President of the Hong Kong Health Food Association, Director of Vita Green Health Products Co., Ltd., Elijandy, Founder and Director of Cross International Ltd and Jones Ng, Founder of Chiwa Digital Media Capital Group Ltd. shared valuable insights in e-commerce marketing and promotion at the launch ceremony. Artist Samantha Ko Hoi Ling talked about her experiences in live-streaming and online shopping, further enhancing the effectiveness and exposure of the second Hong Kong Shopping Festival.Hong Kong Shopping Festival: https://f1546.vrupup.com/s/1546/f/main.html#/Photo Download: http://bit.ly/3IS8gRVPatrick Lau, Deputy Executive Director, HKTDC (third from right); Ryan Tse, President of the Hong Kong Health Food Association, Director of Vita Green Health Products Co., Ltd. (second from right); Elijandy, Founder and Director of Cross International Ltd. (first from left); Jones Ng, Founder of Chiwa Digital Media Capital Group Ltd. (first from right) and Samantha Ko Hoi Ling, Artist (second from left), attend the launch ceremony for the second Hong Kong Shopping Festival.The Hong Kong Special Administrative Region (HKSAR) Government provides full support to the Hong Kong Shopping Festival. Paul Chan, Financial Secretary of the HKSAR Government, filmed a promotional video.Patrick Lau, Deputy Executive Director of HKTDC, announces that as the flagship event of HKTDC's E-commerce Express, the second Hong Kong Shopping Festival will partner with major e-commerce and social media platforms for promotion and include a series of training sessions focused on the Mainland e-commerce market.Irina Fan, HKTDC Director of Research, said over 60% of surveyed Hong Kong businesses view the Mainland Chinese market as the most promising e-commerce market in the coming one to two years.Samantha Ko Hoi Ling, Artist, attends the launch ceremony of the Hong Kong Shopping Festival, promoting Hong Kong’s brands and products.Media EnquiriesYuan Tung Financial Relations:Louise Song Tel: (852) 3428 5691 Email: lsong@yuantung.com.hkTiffany Leung Tel: (852) 3428 2361 Email: tleung@yuantung.com.hk HKTDC’s Communications & Public Affairs Department:Sharon Ha Tel: (852) 2584 4575 Email: sharon.mt.ha@hktdc.orgKaty Wong Tel: (852) 2584 4524 Email: katy.ky.wong@hktdc.orgHKTDC Media Room: https://mediaroom.hktdc.com/enAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.
HKTDC welcomes the ‘Report on Hong Kong’s Business Environment’ and continues to actively promote Hong Kong’s advantages
HONG KONG, July 30, 2025 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Trade Development Council (HKTDC) welcomes the release of the "Report on Hong Kong’s Business Environment: Unique Strengths under 'One Country, Two Systems'" by the Hong Kong Special Administrative Region (HKSAR) today.Prof Frederick Ma, Chairman of the HKTDC, said, "This report details Hong Kong's business environment and advantages in various sectors, providing concrete analyses with cases and data on business opportunities. It will further attract global businesses to leverage Hong Kong's business platform and professional services."Prof Ma also pointed out that under 'One Country, Two Systems', Hong Kong possesses unique advantages in connecting both Hong Kong and international markets, playing a vital role as a superconnector and super value-adder.He continued, "As an international investment and financial centre, Hong Kong can provide diverse financing channels and options for infrastructure projects in the mainland and other regions, contributing to the high-quality development of the Belt and Road Initiative." The 10th Belt and Road Summit will be held from 10 to 11 September, promoting multilateral cooperation.The HKTDC will continue to align with HKSAR policies, actively promoting Hong Kong's business advantages, facilitating international trade and business activities and providing comprehensive support, especially for SMEs.Media enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Sam HoTel: (852) 2584 4569Email: sam.sy.ho@hktdc.org About HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
Santa Clara, CA, July 29, 2025, (ACN Newswire via SeaPRwire.com) - Meshy.ai, the world’s leading AI-powered 3D content generation platform, has launched the Meshy 5 Preview, offering early access to the next generation of AI 3D model generator. Built on the strong foundation of Meshy 4, this preview version introduces smarter generation tools, enhanced image alignment, sharper geometry, and over 500 new animations—empowering creators to build faster, cleaner, and more creatively than ever before.Trusted by 3 Million Creators – The Platform of Choice for Game DevelopersWith over 30 million 3D assets generated and a community of more than 3 million creators, Meshy has become the go-to AI platform for game developers, VFX artists, and 3D content professionals worldwide. Recognized by Andreessen Horowitz (a16z) as the only 3D tool featured in its list of “Most Popular AI Tools Among Game Developers,” Meshy is redefining how digital worlds are built—with speed, accuracy, and creative control.What’s New in Meshy 5 PreviewStronger Image Alignment: Mesh structures now more precisely match the shape and proportions of input images — with support for multi-view input to generate more complete 3D models.Razor-sharp Geometry: From hard-surface mechs to organic characters, edges are sharper and forms more defined.Advanced AI Tools: Now supports Kontext for multi-view generation and a smart AI Prompt Helper to make prompting faster and easier.500+ New Animations: A dramatically expanded animation library for rigged characters, empowering developers and artists with more expressive motion capabilities.“The multi-view support and sharper geometry have made our modelling workflow twice as fast with much less cleanup,” said Victoria C., a senior 3D environment artist at an indie game studio and early Meshy 5 Preview tester. “This version brings us much closer to using AI directly in our production pipeline.”From Meshy 4 to Meshy 5 Preview: A Foundation ReinforcedAbout one year ago, Meshy introduced Meshy 4, which brought improvements in geometry quality, Text to 3D workflow, and retry functionality. Meshy 5 Preview builds on that foundation, offering enhanced mesh coherence, fewer visual defects, and a more structured modelling-to-texturing pipeline—allowing creators to move from concept to completion with unprecedented speed and clarity.Whether generating stylized concepts or rigged production assets, Meshy empowers studios to accelerate creative pipelines, reduce manual workloads, and retain full artistic control. The platform integrates seamlessly with tools like Unity, Unreal Engine, Blender, and ZBrush, and supports advanced rigging and animation workflows out-of-the-box.What Sets Meshy ApartPowered by cutting-edge foundation models, Meshy combines advanced AI technology with industry-leading product capabilities to deliver unparalleled value. Its unique features and user-centric design have established Meshy as the world’s leading AI 3D model generator. Key differentiators include:Hyper-Realistic Texture Generation – Capable of producing highly detailed, natural-looking textures that align with industry standards.Advanced Rigging and Animation Support – Offers ready-to-use rigged models alongside an expanding motion library, significantly streamlining animation workflows.A Thriving Community for Remix & Creative Collaboration – Hosts a vast repository of high-quality, customizable assets, enabling creators to easily remix and build upon existing work.Unmatched Workflow Flexibility – Supports both white and textured model outputs, along with texture swapping via text or images. Artists can effortlessly re-style assets — for example, transforming a realistic model into an ink-wash aesthetic — without starting from scratch.Real Creators. Real Workflows. Real Impact.From indie game developers and VFX artists to educators and avatar designers, creators around the world are embracing Meshy 5 Preview to reimagine the way they build, teach, and tell stories in 3D. Whether it’s speeding up asset production, unlocking new creative directions, or making 3D design accessible to more people—Meshy is becoming a core part of real-world workflows.Explore how Meshy is powering next-gen creativity—one creator at a time.Sivan Okcu – Avatar Creator for Second LifeUses Meshy’s Text to 3D and Image to 3D features to produce stylized avatars faster, reduce costs, and grow his virtual business.“I can explore more styles, lower prices, and sell more—all without sacrificing quality.” Read Sivan’s story → Skylyfe Inc. – Tech Education for Underserved YouthEmpowers students aged 10–30 with hands-on 3D design using Meshy in an 8-week program focused on 3D printing, AR, and VR.“Students said it felt like printing things from your mind into real life.”Read the Skylyfe story → Marcos Medel – VFX Artist & AnimatorTransforms classical paintings into surreal 3D cinematic loops using Meshy to create custom models with AI-enhanced workflows.“Something that could take days or weeks — Meshy can do in just a few clicks.” Read Marcos’s story → David Zhang – Indie Game Developer (Remnants of R’lyeh) Builds weapons, creatures, and deep-sea props using Meshy’s Text-to-3D, accelerating production and enriching a Lovecraft-inspired horror world.“Meshy helped bring my game’s vision to life—faster, cheaper, and more creatively.” Read David’s story → Read More User Stories in the Meshy BlogWhether you’re a creator with a cool workflow or an influencer interested in collaborating, share your project with us at marketing@meshy.ai.Media Contact: Conan Zhang, Meshy.ai, marketing@meshy.ai, www.meshy.ai Distributed by Pinion Newswire. All rights reserved. Copyright 2025 JCN Newswire via SeaPRwire.com.
持續回購顯信心 首程控股以實際行動提振市場預期
香港，2025年7月30日 - (亞太商訊 via SeaPRwire.com) - 近日，首程控股（0697.HK）在港交所公告，於2025年7月29日通過集中競價交易方式回購1765萬股，耗資3230.1萬港元，回購價格區間為1.80至1.86港元。這是公司近一個月內進行的又一次大手筆回購，亦是管理層對公司價值與未來發展的高度認可。據統計，自2025年7月以來，首程控股已累計回購3674.6萬股，合計金額達6673.13萬港元。其中，除7月29日的集中回購外，7月10日公司曾大規模回購1905萬股，金額達3434.64萬港元，成交價區間為1.79至1.80港元。回購是上市公司最具信號意義的資本動作之一。面對短期市場波動，首程控股選擇主動出擊、堅定回購，釋放出強烈的管理層態度：公司將持續秉持對股東負責、對長期價值負責的理念，堅決捍衛企業基本面與市場信心。公司管理層表示：「我們堅定看好首程控股的長期價值，對公司戰略方向、經營基礎及未來發展充滿信心。當前階段的回購，是我們作為上市公司對股東、對市場、對公司負責的應有之舉。我們願意在關鍵時點主動出手，以實際行動穩定市場預期，兌現我們對投資者的長期承諾。」作為中國領先的智能基礎設施資產服務商，首程控股近年來持續深耕股權投資、REITs、產業空間及智慧停車等核心業務板塊，形成良好的資產閉環與現金流體系。在機器人、新型基礎設施等未來產業的投資中，公司亦不斷釋放成長彈性與產業協同價值。業內人士分析認為，在當前港股估值整體偏低、優質資產被低估的背景下，首程控股敢於大規模出手回購，釋放出強烈信號 - 公司將持續以穩健的業績、扎實的產業基礎和高效的資本運作，回饋長期支持的投資者，踐行「長期價值創造者」的企業責任。在基本面支撐與回購護盤的雙重催化下，首程控股未來的市場表現值得期待。Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 亞太商訊 via SeaPRwire.com.
Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB
TOKYO, July 30, 2025 - (JCN Newswire via SeaPRwire.com) - Sharp Corporation has reached an agreement with Mitsubishi Chemical Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Manabu Tsukimoto), the National Institute of Information and Communications Technology (NICT) (Headquarters: Koganei City, Tokyo; President: Hideyuki Tokuda), and TECHLAB Co., Ltd. (Headquarters: Tama City, Tokyo; President: Hiroshi Hatakeyama) to collaboratively develop ultra-compact and lightweight LEO (Low Earth Orbit) satellite communication user terminals for mobility applications.Left: Ultra-Compact and Lightweight LEO Satellite Communication User Terminal;Right: An Image of the Terminal Installed in a VehicleLEO satellite communication enables high-quality, high-speed connectivity even in challenging environments such as mountainous regions, at sea, and on remote islands. Sharp began developing LEO satellite communication user terminals in 2023 (*2), applying design and communication technologies honed through smartphone development to create a compact model (approximately 446 x 446 x 66mm) weighing around 7kg. The goal of this agreement is to accelerate efforts towards practical implementation by fiscal 2025, targeting deployment on vessels and other platforms.With this new agreement, the development of even smaller and lighter LEO satellite communication user terminals will commence in collaboration with Mitsubishi Chemical, NICT, and TECHLAB. A form factor about one-tenth the size (approximately 200 x 200 x 30mm and 1kg) of the currently developed terminal will be aimed through the development of lightweight, high thermal conductivity composite materials and superior heat dissipation designs. By enabling deployment on mobility platforms such as drones and vehicles, applications of LEO satellite communication will be significantly expanded, ensuring communication lines in mountainous areas and disaster zones, enabling real-time location data transmission, and facilitating usage in autonomous vehicles.This initiative will be showcased at the Sharp booth (*2) (South Exhibition Hall, Satellite Data and Space Utilization Area S6-34) and at the Mitsubishi Chemical booth (S7-11) during the "SPEXA - [International] Space Business Exhibition 2025," held at Tokyo Big Sight (Koto-ku, Tokyo) from July 30 (Wednesday) to August 1 (Friday).Roles of Parties Involved- Sharp: Development of LEO satellite communication user terminals utilizing miniaturization and communication technologies cultivated in smartphone design.- Mitsubishi Chemical: Development of new lightweight, high thermal conductivity composite materials for heat dissipation plates.- NICT: Overall design and simulation of antennas for ultra-miniaturization and lightweight structures, including heat dissipation designs.- TECHLAB: Material molding and processing of new materials.Contacts:NTN_B5G@sharp.co.jp*1 This terminal integrates LEO satellite communication antennas and modem functions. LEO stands for Low Earth Orbit.*2 The development of LEO satellite communication user terminals and participation in SPEXA is supported by a grant from the National Institute of Information and Communications Technology (NICT). (JPJ012368G50501) Copyright 2025 JCN Newswire via SeaPRwire.com.
Ongoing Share Buybacks Demonstrate Confidence, Shoucheng Holdings Boosts Market Expectations with Concrete Action
HONG KONG, July 30, 2025 - (ACN Newswire via SeaPRwire.com) - Shoucheng Holdings Limited (0697.HK) recently announced via the Hong Kong Stock Exchange that it repurchased 17.65 million shares through on-market transactions on July 29, 2025, with a total consideration of HK$32.301 million. The repurchase price ranged from HK$1.80 to HK$1.86 per share. This marks another substantial buyback in the past month, reflecting management’s firm confidence in the company’s intrinsic value and long-term development.According to data, since July 2025, Shoucheng Holdings has cumulatively repurchased approximately 36.746 million shares, with a total expenditure of HK$66.7313 million. In addition to the July 29 buyback, the company executed another significant repurchase on July 10, acquiring 19.05 million shares for HK$34.3464 million at a price range of HK$1.79–1.80.Share repurchases are among the strongest signals a listed company can send to the market. In the face of short-term market volatility, Shoucheng has chosen to act decisively, reaffirming its responsibility to shareholders and its long-term value commitment. Management has conveyed a clear message: the company is committed to defending its fundamentals and investor confidence with concrete capital actions.Management stated: “We remain firmly optimistic about the long-term value of Shoucheng Holdings and are confident in our strategic direction, operational foundation, and future growth. This round of repurchases reflects our duty as a listed company to our shareholders, the market, and the company itself. We will continue to step forward at key moments to stabilize expectations and fulfill our long-term commitments to investors.”As a leading smart infrastructure asset operator in China, Shoucheng has deeply invested in core business sectors including equity investment, REITs, industrial real estate, and smart parking. It has built a strong asset cycle and cash flow system. In emerging sectors such as robotics and new infrastructure, the company continues to unlock growth potential and industrial synergy.Industry observers note that in today’s undervalued Hong Kong market, Shoucheng’s large-scale repurchase sends a clear signal: the company is prepared to reward long-term investors through steady performance, solid fundamentals, and disciplined capital management—true to its role as a creator of long-term value.With strong fundamentals and buybacks reinforcing support, Shoucheng Holdings’ future market performance is worth watching.Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 ACN Newswire via SeaPRwire.com.
Wintermar Offshore (WINS:JK) Reports 1H2025 Results
JAKARTA, July 29, 2025 - (ACN Newswire via SeaPRwire.com) - Wintermar’s Operating Profit jumped 55.8%YOY to US$8.9million for 1H2025, derived from 17% growth in Owned Vessel Revenue in 1H2025 and higher gross margins from better fleet mix and higher charter rates.Owned Vessel revenues were higher in 1H2025 compared to 1H2024 despite lower utilization due to better yielding vessels in operation in 1H2025. Owned Vessel DivisionAlthough the number of vessels has not changed, fleet composition has improved with 2 additional PSVs in operation in 1H2025 as well as 3 newly delivered HLBs which 2 units commenced work in April 2025 and 1 unit in July 2025. With 4 additional units of higher yielding vessels in operation compared to last year, gross margins from the Owned Vessels Division expanded from 29.6% in 1H2024 to 39.1% in 1H2025. This resulted in a 54.4%YOY jump in Gross Profit growth for the Owned Vessel Division to US$12.4million, despite a fall in utilization from 63.7% in FY2024 to 57.9% in 1H2025.Despite a slower first half of the year which caused a dip in utilization, the Company reaped the benefit of improving average charter rates from a higher number of operational vessels at the higher value segment of the fleet. Owned Vessel Expenses increased by 22%QOQ from 1Q2025 to 2Q2025 due to an increase of fleet as well as Operational costs. Chartering Division and Other ServicesChartering revenues experienced a sharp decline, as several vessels ended a contract which has not been renewed. Gross Profit from Chartering fell from US$0.7million in 1H2024 to US$0.2million in 1H2025.Gross Profit from Other Services fell to US$1.4million (-11.5%YOY) in1H2025 in line with the lower vessel utilization for the period compared to last year. Direct Expenses and Gross ProfitTotal Owned Vessel Direct Expenses rose only slightly by 1.3%YOY to US$19.4million for 1H2025. The largest increase came from Fuel Bunker costs which rose to US$1.4million (+46.1%YOY) due to the mobilization of vessels to overseas contracts. All other costs were lower except for Fleet Maintenance which rose 2.2%YOY to US$4.1million in 1H2025.On a quarterly basis, there were higher operational and maintenance costs in 2Q2025 compared to 1Q2025 due to the preparation and mobilization of a mid-tier vessel for a long-term contract in the Middle East. Indirect Expenses and Operating ProfitTotal Indirect Expense rose by 11.0%YOY to US$5.1million in 1H2025. The largest increase came from salary and employee benefits which rose by 10.0%YOY and 16.9%YOY to US$3.8million and US$0.2million respectively. With the improvement in business conditions and a wider geographic spread of operations, there was an increase in the number of employees in 2025 compared to last year. Telecommunications and marketing costs also rose with more international projects and higher costs of bid bond fees in the tender process.Due to good cost control, Operating Profit for 1H2025 jumped by 55.8% to US$8.9million from US$5.7million in the previous year. Other Income, Expenses and Net Attributable ProfitAs the Company refinanced the newly acquired vessels from the past year, interest expenses rose to US$1million for 1H2025, while interest income also doubled to US$0.3million due to strong operational cash flow.There was a turnaround in Equity in net earnings of Associates from a loss of US$0.4million in 1Q2025 to a profit of US$0.7million in 2Q2025. This resulted in a gain of US$0.6million from Investment in Associates for 1H2025, slightly lower than US$0.8million in 1H2024.During 2Q2025, management successfully sold a smaller mid-tier vessel for a profit, resulting in a net gain on sale of fixed asset of US$1.7million. This is in line with the continued fleet renewal program where smaller mid-tier vessels which are lower yielding will continue to be sold off to concentrate the fleet on larger and higher yielding vessels. However, this cannot compare with the significant one-off gain of US$17.4million recorded in 1H2024 primarily from the sale of a platform supply vessel. Therefore, total Other Income was US$1.7million for 1H2025 as compared to US$17.4million in 1H2024 which included the one-off vessel sale.Net income before tax for 1H2025 totalled US$10.7million, compared to US$23.2million in 1H2024. This 53.8% decline does not reflect the underlying improvement in the core business as 1H2024 profit included the sizable one-off gain from the vessel sale. Non-Controlling Interest fell from US$6.4 million in 1H2024 which included some profit from the sale of vessel to US$2.7 million in 1H2025. The group’s EBITDA jumped by 25.8%YOY for 1H2025, reaching US$16.0 million compared to US$12.7million in 1H2024.Stripping out the impact of vessel sales, the underlying profit for 1H2025 was US$ 5.4million compared to US$4.9million in 1H2024 representing a growth of 10.1%YOY.Industry Outlook There are growing signs of a pivot from renewable energy back to hydrocarbons as the world faces a growing need for energy while renewable sources of fuel are still insufficient and less economical. The continuing uncertainty in the Middle East and ongoing wars in Ukraine and Gaza have put pressure on governments around the world to seek energy security. In addition, the increasing need for energy for the “Green Transition” and data centres has led to a resurgence of demand for oil and gas. These factors have led to projections for global investment in oil and gas being maintained above US$610 billion in the coming years, with a steadily growing share invested into offshore fields. In Indonesia, the government has continued to push for self-sufficiency in various sectors, with energy being one of the sectors benefitting from this plan. There are at present four sizeable strategic national projects in Indonesian offshore fields which are currently in the early stage of exploration and where production is expected from 2026-2030. These projects will sustain demand for OSVs in Indonesia in the coming years.Business ProspectsThe Company’s focus on developing a strong presence in the dynamic positioning segment is bringing in benefits of a higher blended fleet charter rate which has led to higher gross margins. The 3 units of newly built HLB which commenced work in April to July 2025 will underpin earnings in 2H2025, and there is a third reactivated PSV expected to be operational at the end of 3Q2025. The investment cycle for oil and gas is still expected to ramp up for the next few years, providing better fleet utilization which will lead to profit upside.The stronger cash flow arising from a low debt position has enabled the Company to continue investing into higher value vessels while selling lower yielding vessels. The additional vessels coming into operation in 2025 will provide upside for 2026 earnings. Total contracts on hand as at end June 2025 has risen to US$70.9 million.About Wintermar Offshore Marine GroupWintermar Offshore Marine Group (WINS.JK), developed over nearly 50 years with a track record of quality that is both a source of pride and responsibility that we are dedicated to upholding, and sails a fleet of more than 48 Offshore Support Vessels ready for long term as well as spot charters. All vessels are operated by experienced Indonesian crew, tracked by satellite systems and monitored in real-time by shore-based Vessel Teams.Wintermar is the first shipping company in Indonesia to be certified with an Integrated Management System by Lloyd's Register Quality Assurance, and is currently certified with ISO 9001:2015 (Quality), ISO14001:2015 (Environment) and OHSAS 18001:2007 (Occupational Health and Safety). For more information, please visit www.wintermar.com.For further information, please contact:Ms. Pek Swan Layanto, CFAInvestor RelationsPT Wintermar Offshore Marine TbkTel (62-21) 530 5201 Ext 401Email: investor_relations@wintermar.com Copyright 2025 ACN Newswire via SeaPRwire.com.
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
Mitsubishi Heavy Industries aims to integrate DCIM (Data Center Infrastructure Management) into its One-stop solutions portfolio to offer digital services to data centersThe combination delivers a comprehensive view of data center infrastructure, enabling enhanced visibility, elevated operational efficiency and optimized energy consumptionTOKYO, July 29, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) has concluded an agreement with Modius® Inc., a US based provider of innovative software solutions for managing critical facilities for the data center and telecommunications markets. Under this agreement, MHI will integrate Modius's OpenData® DCIM technology with MHI's power, cooling, and control technologies to deliver a unique, market leading solution for Data Center Energy Management (DCEM). This collaboration is an example of MHI Group's partnering efforts, and MHI Group will continue to build strategic partnerships globally.Modius's OpenData DCIM platform provides real-time insights into data center infrastructure, enabling capacity management, improved uptime and enhanced energy efficiency. With over 250 deployments worldwide, Modius has gained customer trust for delivering reliable and sustainable solutions that optimize operations and reduce environmental impact.With rapid scaling of digital infrastructure globally and frequent upgrades to IT systems, it is becoming an overwhelming challenge to manage the reliable operation of data centers while also being energy efficient. The OpenData® AI/ML module strengthens MHI's One-stop Solutions Portfolio by enabling real-time anomaly detection and proactive diagnostics. By self-learning the "normal" behavior of data centers, the AI system empowers operators to address issues before they escalate. By combining Modius's real time monitoring and AI/ML driven analytics with MHI's cutting-edge engineering solutions, the joint offering will empower customers to proactively manage capacity, minimize downtime, and improve sustainability."MHI is committed to delivering sustainable and energy efficient data center solutions," said Shin Gomi, Senior General Manager, DCEM at MHI. "With the addition of the Modius DCIM platform to our digital solution portfolio, we can offer digital services to both existing and new customers seeking enhanced visibility and optimization for building next-generation data centers.""MHI's global presence and its alignment with our mission to drive efficiency, improve sustainability, and optimize performance in data centers make this collaboration a perfect fit," said Craig Compiano, President at Modius. "We are excited to work with MHI to deliver our DCIM solutions alongside their advanced technologies to customers worldwide.Mitsubishi Heavy Industries Group is delivering more sustainable and reliable solutions to data centers by combining decarbonized power generation, reliable power distribution, high efficiency cooling systems and Integrated Digital Solutions. We support our customers through the complete lifecycle from design phase to post deployment with actionable insights, solutions and services.About ModiusModius Inc. is a leading innovator in Data Center Infrastructure Management (DCIM) solutions, providing real-time visibility and decision support for managing distributed equipment across data centers, telecommunications networks, and other critical facilities. The company's flagship product, OpenData, is an edge-ready asset performance management platform designed to optimize the availability, capacity, and efficiency of critical infrastructure. For more information about Modius Inc. and the OpenData platform, please visit Modius.comAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2025 JCN Newswire via SeaPRwire.com.